Asthma and COVID-19

Abrams, Elissa M.; Jong, Geert W. ‘t; Yang, Connie L.

doi:10.1503/cmaj.200617

Cited by 69 publications

(89 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This may be due to the small number of deaths in our sample. Although an association between asthma and poor outcomes has been suggested by some authors 23,24 , we did not find any other studies that have reported this.…”

Section: Discussioncontrasting

confidence: 64%

“…This was longer that the median length of stay observed in similar studies 1,2 . In addition, the length of stay was longer in older patients, above 65 years of age in our sample (24 days, IQR [18][19][20][21][22][23][24][25][26][27][28][29][30][31]. This may reflect the stringent discharge criteria at our center (2 consecutive nasopharyngeal swabs, 24 hours apart after symptom resolution).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical Characteristics, Risk Factors and Outcomes Among the First Consecutive 1,096 Patients Diagnosed with COVID-19: The Kuwait Experience

Almazeedi

Youha

Jamal

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 64%

Section: Discussionmentioning

confidence: 99%

Clinical Characteristics, Risk Factors and Outcomes Among the First Consecutive 1,096 Patients Diagnosed with COVID-19: The Kuwait Experience

Almazeedi

Youha

Jamal

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…Recent studies from the United States and United Kingdom have shown that patients with asthma are over-represented among adult patients with COVID-19, who were admitted to hospital. 9 - 11 A study conducted by Chiba et al evaluated 1526 PCR confirmed Covid positive patients and found that 220 (14%) of patients had comorbid asthma. 12 However, comorbid asthma was not found to increase risk of hospitalization in this study population.…”

Section: Does Asthma Increase the Risk Of Covid-19 Infection (See mentioning

confidence: 99%

“…Instead a metered-dose inhaler with a valved holding chamber or dry powdered inhaler are preferred to reduce auto-aerosolization and spread of virus into the surrounding environment. 9 , 29 Patients currently on nebulized medications should continue on these medications only until their provider can discuss with them the alternative medication options. 29 …”

Section: What Do We Know About the Treatment Of Asthma During The Covmentioning

confidence: 99%

Asthma and COVID-19: What do we know now

Hughes-Visentin

Paul

2020

Clin Med Insights Circ Respir Pulm Med

View full text Add to dashboard Cite

The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma. Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how underlying asthma affects Covid-19 risk, symptomology and prognosis. In light of this unique medical challenge, clinicians are faced with case-by-case based decisions to implement or continue current asthma therapy. This review will discuss the current literature regarding asthma and COVID-19 based on best available evidence at this time (See box 1).

show abstract

“…Groups of increased risk are men, pregnant and postpartum women, and individuals with high occupational viral exposure [229][230][231]. Other susceptibility factors include the ABO blood groups [232][233][234][235][236][237][238][239][240] and respiratory conditions [241][242][243][244][245][246].…”

Section: Susceptibility Features Of the Hostmentioning

confidence: 99%

COVID-19 Disease Map, a computational knowledge repository of SARS-CoV-2 virus-host interaction mechanisms

Ostaszewski

Niarakis

Mazein

et al. 2020

Preprint

View full text Add to dashboard Cite

We hereby describe a large-scale community effort to build an open-access, interoperable, and computable repository of COVID-19 molecular mechanisms - the COVID-19 Disease Map. We discuss the tools, platforms, and guidelines necessary for the distributed development of its contents by a multi-faceted community of biocurators, domain experts, bioinformaticians, and computational biologists. We highlight the role of relevant databases and text mining approaches in enrichment and validation of the curated mechanisms. We describe the contents of the map and their relevance to the molecular pathophysiology of COVID-19 and the analytical and computational modelling approaches that can be applied to the contents of the COVID-19 Disease Map for mechanistic data interpretation and predictions. We conclude by demonstrating concrete applications of our work through several use cases.

show abstract

Asthma and COVID-19

Cited by 69 publications

References 3 publications

Clinical Characteristics, Risk Factors and Outcomes Among the First Consecutive 1,096 Patients Diagnosed with COVID-19: The Kuwait Experience

Clinical Characteristics, Risk Factors and Outcomes Among the First Consecutive 1,096 Patients Diagnosed with COVID-19: The Kuwait Experience

Asthma and COVID-19: What do we know now

COVID-19 Disease Map, a computational knowledge repository of SARS-CoV-2 virus-host interaction mechanisms

Contact Info

Product

Resources

About